[Effect of mestranol and chlormadinone acetate on HGH secretion in Turner's syndrome].
In 19 patients aged from 12 to 24 years (average age 17.0 years) with Turner's syndrome the influence of the hormonal substitution with mestranol and chlormadinone acetate on both basal and arginine stimulated HGH secretion was investigated. This test was performed before, during and after treatment. HGH serum levels were determined by RIA. Both the basal values and the increase of HGH secretion after arginine stimulation were used for evaluation of the test results. Under estrogen-gestagen treatment in 15 of the 19 patients hypersomatotropic basal levels were determined. The basal HGH levels before and during as well as during and after treatment are significant different (p less than 0,01). The responsibility of the somatotrophs to the arginine stimulation was individually different and did not show any uniform trend.
K
K
Rudolf
S
S
Kunkel
K P
KP
Woltanski
D000293:Adolescent; D000328:Adult; D001120:Arginine; D002648:Child; D002715:Chlormadinone Acetate / Q000627:therapeutic use*; D006063:Chorionic Gonadotropin / Q000097:blood*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008656:Mestranol / Q000627:therapeutic use*; D010906:Pituitary Hormone-Releasing Hormones; D013973:Thyrotropin-Releasing Hormone; D014424:Turner Syndrome / Q000097:blood / Q000188:drug therapy*
D006063:Chorionic Gonadotropin; D010906:Pituitary Hormone-Releasing Hormones; D002715:Chlormadinone Acetate; D013973:Thyrotropin-Releasing Hormone; D001120:Arginine; D008656:Mestranol
Einfluss von Mestranol und Chlormadinonazetat auf die HGH-Sekretion beim Turner-Syndrom.